Attachment 1 Purchase-Description_Medtrack_4.24.2024.docx

DOCX document 29 KB Posted

Attached to
Biomedtracker (including Enhanced Company Deals Upgrade)
Solicitation number
75N95024Q00344
Issued by

About this file

Written by GovTribe AI ·

This document is a Notice of Intent to conduct a sole-source procurement for a one-year software license for Biomedtracker and Enhanced Company Deals Upgrade licenses by the National Center for Advancing Translational Science (NCATS) Office of Strategic Alliances (OSA). NCATS OSA requires the software to conduct research on innovations and technology development related to NCATS research, with specific requirements for reporting tools, exportable data, and access to expert analysts. The intended sole-source award is to Citeline/Caerus US 1 Inc., the only vendor that can meet the requirements. The period of performance is June 24, 2024 to June 23, 2025. Responses to this notice with capability statements, pricing, and other information are due by June 24, 2024 at 11:00 AM EST. This procurement is conducted under FAR Part 13 Simplified Acquisition Procedures and is exempt from full and open competition requirements.

View the file

Other files

File Type Posted
Amendment 1.pdf PDF
B Sole-Source-Justification-FS.pdf PDF
Attachment 5 FAR 52.212-4 Addendum.pdf PDF
Attachment 2 FAR 52.212-5 (May 2024)_.pdf PDF
Attachment 3 NIH Electronic Invoicing Submission Instructions.pdf PDF
Attachment 4 Invoicing Instructions with IPP Mar 2023.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

PURCHASE DESCRIPTION

1. Statement of Need and Purpose:

The purpose of this acquisition is to procure database software licenses which provide access to medical drug information as well as associated companies, patents, technologies, and agreements via a single platform.

2. Background Information and Objective:

The National Center for Advancing Translational Science (NCATS) Office of Strategic Alliances (OSA) works to support collaboration between academic research institutions and scientific pharmacological industry organizations. OSA works in particular to address intellectual property (IP) issues by reviewing and tracking new innovations and developing strategies for patent filing and partnering. NCATS OSA therefore requires software tools to conduct research on innovations and technology development releated to NCATS research.

3. Generic Name of Product:

Biomedtracker (including Enhanced Company Deals Upgrade)

4. Purchase Description:

The NCATS OSA requires five (5) one-year software licenses for a single-platform database providing access to pharmaceutical information as well as associated companies, patents, technologies, and agreements

5. Salient characteristics:

NCATS requires access to reporting tools for chemical structures, royalties, milestones, epidemiology, and sales. The database should be able to export the requested information out into excel, we would like to see columns such as deals, companies, products, mechanism of action, class, deal value, and upfront cash. If possible OSA would like to have access to online support expert analyst who can answer questions about products, sales, deals, mergers, venture capital investments and partnerships.

6. Quantity:

Five (5) One-Year Software Licenses are required.

7. Delivery Date:

Software licenses shall be delivered electronically by or before 06/26/2024.

8. Period of Performance:

Software licenses must be valid for a one year period of performance.

9. Option(s):

N/A

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

File details come from the government source that posted it. Updated .